The North America Newborn Screening Market would witness market growth of 5.8% CAGR during the forecast period (2022-2028).
Each state has its series of tests, parents can also look up what condition’s tests for baby. The Recommended Uniform Screening Panel, or RUSP, is a list of health conditions that HHS recommends. Newborn screening helps in identify health conditions such as metabolism, the process of converting food into energy that the body can utilize to walk, think, and develop. Enzymes are proteins that aid metabolism by accelerating chemical reactions within cells. The majority of metabolic issues arise when particular enzymes are absent or aren't functioning properly. Hormone imbalances occur when glands produce too many or too few hormones. The protein hemoglobin is found in red blood cells and is responsible for transporting oxygen around the body.
State or highest decision-making organizations frequently undertake screening programs with the purpose of screening all newborns born in their territory for a defined array of curable illnesses. Each jurisdiction determines the variety of diseases examined, which can vary substantially. The majority of NBS tests rely on metabolites or enzymatic activities being measured in whole blood samples taken on filter paper. Some NBS programs offer bedside testing for hearing problems using the automatic auditory brainstem reaction and congenital cardiac abnormalities utilizing pulse oximetry. Geneticists, children's pediatricians, or their primary care physicians organize follow-up tests for babies who test positive, in order to determine if they are sick or if the result was a false positive.
Considering border limitations to halt the spread of COVID-19, Canada's population increase has halted. Although the populace continued to expand over the 12 months ending June 30, 2021, the rate of growth was less than half that observed a year earlier and was the smallest since the First World War in 1915-1916. As of July 1, 2021, Canada's population had increased by 208,904 people a year over year, to an anticipated 38,246,108 people. In comparison, over the same period in 2019/2020, the Canadian population grew at a rate of over double that.
The US market dominated the North America Newborn Screening Market by Country in 2021, and would continue to be a dominant market till 2028; thereby, achieving a market value of $417.6 Million by 2028. The Canada market is poised to grow at a CAGR of 8.2% during (2022 - 2028). Additionally, The Mexico market is anticipated to grow at a CAGR of 7.2% during (2022 - 2028).
Based on Product Type, the market is segmented into Consumables and Instrument. Based on Test Type, the market is segmented into Blood Test, Hearing Screening Test, and Heart screening. Based on End User, the market is segmented into Hospitals and Clinical Laboratories. Based on Technology, the market is segmented into Tandem Mass Spectrometry (TMS), Molecular Assays, Immunoassays & Enzymatic Assays, Hearing Screen Technology, Pulse Oximetry Screening Technology, Others. Based on countries, the market is segmented into U.S., Mexico, Canada, and Rest of North America.
Free Valuable Insights: The Global Newborn Screening Market is Estimated to reach $1.6 Billion by 2028, at a CAGR of 6.4%
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include General Electric (GE) Co. (GE Healthcare), F. Hoffmann-La Roche Ltd., Bio-Rad Laboratories, Inc., Natus Medical Incorporated, Masimo Corporation, Waters Corporation, PerkinElmer, Inc., AB Sciex LLC (Danaher Corporation), Medtronic PLC (Covidien plc), Trivitron Healthcare Pvt. Ltd.
Scope of the Study
Market Segments Covered in the Report:
By Product Type
By Test Type
- Blood Test
- Hearing Screening Test
- Heart screening
By End User
- Hospitals
- Clinical Laboratories
By Technology
- Tandem Mass Spectrometry (TMS)
- Molecular Assays
- Immunoassays & Enzymatic Assays
- Hearing Screen Technology
- Pulse Oximetry Screening Technology
- Others
By Country
- US
- Canada
- Mexico
- Rest of North America
Key Market Players
List of Companies Profiled in the Report:
- General Electric (GE) Co. (GE Healthcare)
- F. Hoffmann-La Roche Ltd.
- Bio-Rad Laboratories, Inc.
- Natus Medical Incorporated
- Masimo Corporation
- Waters Corporation
- PerkinElmer, Inc.
- AB Sciex LLC (Danaher Corporation)
- Medtronic PLC (Covidien plc)
- Trivitron Healthcare Pvt. Ltd.
Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 North America Newborn Screening Market, by Product Type
1.4.2 North America Newborn Screening Market, by Test Type
1.4.3 North America Newborn Screening Market, by End User
1.4.4 North America Newborn Screening Market, by Technology
1.4.5 North America Newborn Screening Market, by Country
1.5 Methodology for the research
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.1.1 Market composition & scenarios
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. Strategies Deployed in Newborn Screening Market
Chapter 4. North America Newborn Screening Market by Product Type
4.1 North America Consumables Market by Country
4.2 North America Instrument Market by Country
Chapter 5. North America Newborn Screening Market by Test Type
5.1 North America Blood Test Market by Country
5.2 North America Hearing Screening Test Market by Country
5.3 North America Heart screening Market by Country
Chapter 6. North America Newborn Screening Market by End User
6.1 North America Hospitals Market by Country
6.2 North America Clinical Laboratories Market by Country
Chapter 7. North America Newborn Screening Market by Technology
7.1 North America Tandem Mass Spectrometry (TMS) Market by Country
7.2 North America Molecular Assays Market by Country
7.3 North America Immunoassays & Enzymatic Assays Market by Country
7.4 North America Hearing Screen Technology Market by Country
7.5 North America Pulse Oximetry Screening Technology Market by Country
7.6 North America Others Market by Country
Chapter 8. North America Newborn Screening Market by Country
8.1 US Newborn Screening Market
8.1.1 US Newborn Screening Market by Product Type
8.1.2 US Newborn Screening Market by Test Type
8.1.3 US Newborn Screening Market by End User
8.1.4 US Newborn Screening Market by Technology
8.2 Canada Newborn Screening Market
8.2.1 Canada Newborn Screening Market by Product Type
8.2.2 Canada Newborn Screening Market by Test Type
8.2.3 Canada Newborn Screening Market by End User
8.2.4 Canada Newborn Screening Market by Technology
8.3 Mexico Newborn Screening Market
8.3.1 Mexico Newborn Screening Market by Product Type
8.3.2 Mexico Newborn Screening Market by Test Type
8.3.3 Mexico Newborn Screening Market by End User
8.3.4 Mexico Newborn Screening Market by Technology
8.4 Rest of North America Newborn Screening Market
8.4.1 Rest of North America Newborn Screening Market by Product Type
8.4.2 Rest of North America Newborn Screening Market by Test Type
8.4.3 Rest of North America Newborn Screening Market by End User
8.4.4 Rest of North America Newborn Screening Market by Technology
Chapter 9. Company Profiles
9.1 General Electric (GE) Co. (GE Healthcare)
9.1.1 Company Overview
9.1.1 Financial Analysis
9.1.2 Segmental and Regional Analysis
9.1.3 Research & Development Expense
9.1.4 Recent strategies and developments:
9.1.4.1 Acquisition and Mergers:
9.1.5 SWOT Analysis
9.2 F. Hoffmann-La Roche Ltd.
9.2.1 Company Overview
9.2.2 Financial Analysis
9.2.3 Segmental and Regional Analysis
9.2.4 Research & Development Expense
9.3 Bio-Rad laboratories, Inc.
9.3.1 Company Overview
9.3.2 Financial Analysis
9.3.3 Segmental and Regional Analysis
9.3.4 Research & Development Expenses
9.4 Natus Medical Incorporated
9.4.1 Company Overview
9.4.2 Financial Analysis
9.4.3 Regional & Segmental Analysis
9.4.4 Research & Development Expenses
9.4.5 Recent strategies and developments:
9.4.5.1 Partnerships, Collaborations, and Agreements:
9.4.5.2 Acquisition and Mergers:
9.5 Masimo Corporation
9.5.1 Company Overview
9.5.2 Financial Analysis
9.5.3 Regional Analysis
9.5.4 Research & Development Expense
9.5.5 Recent strategies and developments:
9.5.5.1 Product Launches and Product Expansions:
9.5.5.2 Approvals and Trials:
9.6 Waters Corporation
9.6.1 Company Overview
9.6.2 Financial Analysis
9.6.3 Segmental and Regional Analysis
9.6.4 Research & Development Expense
9.7 PerkinElmer, Inc.
9.7.1 Company Overview
9.7.2 Financial Analysis
9.7.3 Segmental and Regional Analysis
9.7.4 Research & Development Expense
9.7.5 Recent strategies and developments:
9.7.5.1 Approvals and Trials:
9.8 AB Sciex LLC (Danaher Corporation)
9.8.1 Company Overview
9.8.2 Financial Analysis
9.8.3 Segmental and Regional Analysis
9.8.4 Research & Development Expense
9.9 Medtronic PLC (Covidien plc)
9.9.1 Company overview
9.9.2 Financial Analysis
9.9.3 Segmental and Regional Analysis
9.9.4 Research & Development Expenses
9.9.5 SWOT Analysis
9.10. Trivitron Healthcare Pvt. Ltd.
9.10.1 Company Overview
TABLE 1 North America Newborn Screening Market, 2018 - 2021, USD Million
TABLE 2 North America Newborn Screening Market, 2022 - 2028, USD Million
TABLE 3 North America Newborn Screening Market by Product Type, 2018 - 2021, USD Million
TABLE 4 North America Newborn Screening Market by Product Type, 2022 - 2028, USD Million
TABLE 5 North America Consumables Market by Country, 2018 - 2021, USD Million
TABLE 6 North America Consumables Market by Country, 2022 - 2028, USD Million
TABLE 7 North America Instrument Market by Country, 2018 - 2021, USD Million
TABLE 8 North America Instrument Market by Country, 2022 - 2028, USD Million
TABLE 9 North America Newborn Screening Market by Test Type, 2018 - 2021, USD Million
TABLE 10 North America Newborn Screening Market by Test Type, 2022 - 2028, USD Million
TABLE 11 North America Blood Test Market by Country, 2018 - 2021, USD Million
TABLE 12 North America Blood Test Market by Country, 2022 - 2028, USD Million
TABLE 13 North America Hearing Screening Test Market by Country, 2018 - 2021, USD Million
TABLE 14 North America Hearing Screening Test Market by Country, 2022 - 2028, USD Million
TABLE 15 North America Heart screening Market by Country, 2018 - 2021, USD Million
TABLE 16 North America Heart screening Market by Country, 2022 - 2028, USD Million
TABLE 17 North America Newborn Screening Market by End User, 2018 - 2021, USD Million
TABLE 18 North America Newborn Screening Market by End User, 2022 - 2028, USD Million
TABLE 19 North America Hospitals Market by Country, 2018 - 2021, USD Million
TABLE 20 North America Hospitals Market by Country, 2022 - 2028, USD Million
TABLE 21 North America Clinical Laboratories Market by Country, 2018 - 2021, USD Million
TABLE 22 North America Clinical Laboratories Market by Country, 2022 - 2028, USD Million
TABLE 23 North America Newborn Screening Market by Technology, 2018 - 2021, USD Million
TABLE 24 North America Newborn Screening Market by Technology, 2022 - 2028, USD Million
TABLE 25 North America Tandem Mass Spectrometry (TMS) Market by Country, 2018 - 2021, USD Million
TABLE 26 North America Tandem Mass Spectrometry (TMS) Market by Country, 2022 - 2028, USD Million
TABLE 27 North America Molecular Assays Market by Country, 2018 - 2021, USD Million
TABLE 28 North America Molecular Assays Market by Country, 2022 - 2028, USD Million
TABLE 29 North America Immunoassays & Enzymatic Assays Market by Country, 2018 - 2021, USD Million
TABLE 30 North America Immunoassays & Enzymatic Assays Market by Country, 2022 - 2028, USD Million
TABLE 31 North America Hearing Screen Technology Market by Country, 2018 - 2021, USD Million
TABLE 32 North America Hearing Screen Technology Market by Country, 2022 - 2028, USD Million
TABLE 33 North America Pulse Oximetry Screening Technology Market by Country, 2018 - 2021, USD Million
TABLE 34 North America Pulse Oximetry Screening Technology Market by Country, 2022 - 2028, USD Million
TABLE 35 North America Others Market by Country, 2018 - 2021, USD Million
TABLE 36 North America Others Market by Country, 2022 - 2028, USD Million
TABLE 37 North America Newborn Screening Market by Country, 2018 - 2021, USD Million
TABLE 38 North America Newborn Screening Market by Country, 2022 - 2028, USD Million
TABLE 39 US Newborn Screening Market, 2018 - 2021, USD Million
TABLE 40 US Newborn Screening Market, 2022 - 2028, USD Million
TABLE 41 US Newborn Screening Market by Product Type, 2018 - 2021, USD Million
TABLE 42 US Newborn Screening Market by Product Type, 2022 - 2028, USD Million
TABLE 43 US Newborn Screening Market by Test Type, 2018 - 2021, USD Million
TABLE 44 US Newborn Screening Market by Test Type, 2022 - 2028, USD Million
TABLE 45 US Newborn Screening Market by End User, 2018 - 2021, USD Million
TABLE 46 US Newborn Screening Market by End User, 2022 - 2028, USD Million
TABLE 47 US Newborn Screening Market by Technology, 2018 - 2021, USD Million
TABLE 48 US Newborn Screening Market by Technology, 2022 - 2028, USD Million
TABLE 49 Canada Newborn Screening Market, 2018 - 2021, USD Million
TABLE 50 Canada Newborn Screening Market, 2022 - 2028, USD Million
TABLE 51 Canada Newborn Screening Market by Product Type, 2018 - 2021, USD Million
TABLE 52 Canada Newborn Screening Market by Product Type, 2022 - 2028, USD Million
TABLE 53 Canada Newborn Screening Market by Test Type, 2018 - 2021, USD Million
TABLE 54 Canada Newborn Screening Market by Test Type, 2022 - 2028, USD Million
TABLE 55 Canada Newborn Screening Market by End User, 2018 - 2021, USD Million
TABLE 56 Canada Newborn Screening Market by End User, 2022 - 2028, USD Million
TABLE 57 Canada Newborn Screening Market by Technology, 2018 - 2021, USD Million
TABLE 58 Canada Newborn Screening Market by Technology, 2022 - 2028, USD Million
TABLE 59 Mexico Newborn Screening Market, 2018 - 2021, USD Million
TABLE 60 Mexico Newborn Screening Market, 2022 - 2028, USD Million
TABLE 61 Mexico Newborn Screening Market by Product Type, 2018 - 2021, USD Million
TABLE 62 Mexico Newborn Screening Market by Product Type, 2022 - 2028, USD Million
TABLE 63 Mexico Newborn Screening Market by Test Type, 2018 - 2021, USD Million
TABLE 64 Mexico Newborn Screening Market by Test Type, 2022 - 2028, USD Million
TABLE 65 Mexico Newborn Screening Market by End User, 2018 - 2021, USD Million
TABLE 66 Mexico Newborn Screening Market by End User, 2022 - 2028, USD Million
TABLE 67 Mexico Newborn Screening Market by Technology, 2018 - 2021, USD Million
TABLE 68 Mexico Newborn Screening Market by Technology, 2022 - 2028, USD Million
TABLE 69 Rest of North America Newborn Screening Market, 2018 - 2021, USD Million
TABLE 70 Rest of North America Newborn Screening Market, 2022 - 2028, USD Million
TABLE 71 Rest of North America Newborn Screening Market by Product Type, 2018 - 2021, USD Million
TABLE 72 Rest of North America Newborn Screening Market by Product Type, 2022 - 2028, USD Million
TABLE 73 Rest of North America Newborn Screening Market by Test Type, 2018 - 2021, USD Million
TABLE 74 Rest of North America Newborn Screening Market by Test Type, 2022 - 2028, USD Million
TABLE 75 Rest of North America Newborn Screening Market by End User, 2018 - 2021, USD Million
TABLE 76 Rest of North America Newborn Screening Market by End User, 2022 - 2028, USD Million
TABLE 77 Rest of North America Newborn Screening Market by Technology, 2018 - 2021, USD Million
TABLE 78 Rest of North America Newborn Screening Market by Technology, 2022 - 2028, USD Million
TABLE 79 Key Information – General Electric (GE) Co.
TABLE 80 KEY INFORMATION – F. Hoffmann-La Roche Ltd.
TABLE 81 Key Information – Bio-Rad Laboratories, Inc.
TABLE 82 Key Information – Natus Medical Incorporated
TABLE 83 key Information – Masimo Corporation
TABLE 84 Key Information – Waters Corporation
TABLE 85 key Information – PerkinElmer, Inc.
TABLE 86 Key Information – AB Sciex LLC
TABLE 87 Key Information – Medtronic PLC
TABLE 88 Key Information – Trivitron Healthcare Pvt. Ltd.
List of Figures
FIG 1 Methodology for the research
FIG 2 Swot analysis: General electric (GE) Co.
FIG 3 Recent strategies and developments: Masimo Corporation
FIG 4 Swot analysis: Medtronic plc